Last deal

$6M

Amount

Series B

Stage

18.08.2023

Date

14

all rounds

$37.2M

Total amount

General

About Company
Astrocyte Pharmaceuticals is a drug development company focused on improving the recovery and well-being of brain injury patients.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company utilizes an innovative Cerebro protective strategy to enhance energy production in astrocytes, which are cells in the brain. This approach promotes healing mechanisms that protect against various issues like edema, glutamate excitotoxicity, and oxidative stress. Astrocyte Pharmaceuticals aims to provide advanced acute treatments for stroke, traumatic brain injury (TBI), concussion, and chronic treatments for neurodegenerative disorders like Alzheimer's disease. Through their research and development efforts, they are dedicated to proving the neuroprotective benefits of enhanced mitochondrial energy production in astrocytes and advancing breakthrough therapeutic agents for brain injury treatment.
Contacts